Atlas Trials

Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine

Clinical trial NCT04508075 · COMPLETED

Trial details

NCT number
NCT04508075
Sponsor
PT Bio Farma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SARS-CoV2 Infection
Start date
2020-08-10
Primary completion
2021-01-09
Enrollment
1620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.